The influence of some dietary components on intestinal microbiota by Abruzzo, A. et al.
                   Mattioli 1885
progress in 
nutrition
Indexed in Science Citation Index Expanded (SciSearch®); Journal Citation Reports/Science Edition; Excerpta Medica/Embase, ISI Web of Science
Impact Factor: 0,312
Progr. in Nutr. - Vol. 18 - N. 3 - September 2016 | ISSN 1129-8723
Pu
bb
lic
az
io
ne
 tr
im
es
tra
le
 - 
Po
st
e 
Ita
lia
ne
 s
.p
.a
. -
 S
pe
d.
 in
 A
.P
. -
 D
.L
. 3
53
/2
00
3 
(c
on
v.
 in
 L
. 2
7/
02
/2
00
4 
n.
 4
6)
 a
rt.
 1
, c
om
m
a 
1,
 D
CB
 P
ar
m
a 
- F
in
ito
 d
i s
ta
m
pa
re
  S
et
te
m
br
e 
 2
01
6
Journal of Nutrition and Internal Medicine
www.stardea.com
1 Compressa al giorno
Senza Glutine
FORTEDIF1STAT®* (Lievito di riso rosso con Monacolina K 10 mg,Policosanolo, Niacina), Olea Europaea, Coenzima Q10, Acido Folico e Vitamine. *associazione brevettata n. 1347883
INFORMAZIONI NUTRIZIONALI
COMPONENTI per compressa %VNR
  per compressa
% VNR = percentuale dei Valori Nutritivi di Riferimento (Regolamento UE 1169/2011)
Monascus purpureus e.s. (Lievito rosso) 200  mg
)K anilocanom id gm 01 a irap( )K anilocanom ni %5 .tit(
Olea europaea L. e.s. 100  mg
(tit. 6% in oleuropeina)
Coenzima Q10 5  mg
Camellia sinensis e.s. (tè verde) 100  mg
(tit. 40% in polifenoli) 
Alcoli alifatici lineari (Policosanolo) 10  mg
(tit. 60% in octacosanolo)
Niacina (Vit. PP) 27  mg 169%
Tocoferolo (Vit. E) 20  mg 167%
Piridossina (Vit. B6) 2  mg 143%
Acido folico 300  mcg 150%
Cianocobalamina (Vit. B12) 1 mcg 40%
La Monacolina K 10 mg aiuta a 
conservare i normali livelli di 
colesterolo nel sangue
Gli integratori non vanno intesi come sostituti di una dieta variata, 
equilibrata e di uno stile di vita sano
00-COPERTINA 3.indd   1 29/09/16   11:36
Progress in nutrition
 
 J o u r n a l  o f  n u t r i t i o n a l  a n d  i n t e r n a l  m e d i c i n e
PUBLISHER
Mattioli 1885 srl Casa Editrice
Strada di Lodesana, 649/sx, Loc. Vaio
43036 Fidenza (PR), Italy
Tel. ++39 0524 530383
Fax ++39 0524 82537
E-mail: edit@mattioli1885.com
www.progressinnutrition.it
Organo Ufficiale della Società Italiana di Scienza  dell’Alimentazione (S.I.S.A.)
Con il patrocinio dell’Associazione Ricercatori di Nutrizione e Alimenti (A.R.N.A.)
F. Arfini
Università di Parma
D. Atkinson
Scottish Agricultural College, Edinburgh
G. Ballarini
Università di Parma
S. Bernasconi
Università di Parma
R. Berni Canani
Università di Napoli
G. Bertoni
Università di Piacenza
S.E. Carlson
Kansas City University
E.L. Cavalieri
University of Nebraska
F. Di Lisa
Università di Padova
G. Fatati
Università di Terni
N.G. Frega
Università di Ancona
C. Galli
Università di Milano
C. Giacomini
Università di Parma
M. Gualerzi
Direttore Sanitario Terme di Salsomaggiore e Tabiano, Parma
G.M. Halpern
Hong Kong Polytechnic University
E.L. Iorio
Presidente Osservatorio Internazionale dello  
Stress Ossidativo, Salerno
T. Leighton
Berkeley Università
M.C. Mancini
Università di Parma
R. Marchelli
Università di Parma
P. Migliaccio
Università Sapienza di Roma
A.L. Mordenti
Università di Bologna
K. Mullis
Premio Nobel per la Chimica 1993
S.M. Nabavi
Baqiyatallah University of Medical Sciences, Tehran, Iran
F. Nicastro
Università di Bari
R.C. Noble
Scottish Agricultural College of Edinburgh
B. Palmieri
Università degli Studi di Modena e Reggio Emilia
G. Palmieri
Primario Emerito Medicina Interna, Azienda Ospedaliera 
Ospedale Niguarda Ca’ Granda, Milano
G. Riccardi
Università di Napoli
C.M. Rotella
Università di Firenze
CoMITATo SCIENTIFICo / ExECUTIVE EDIToRS
FoNDAToRE / FoUNDING EDIToR
Massimo Cocchi
Scottish Agricultural College, Edinburgh
DIRETToRE SCIENTIFICo / EDIToR
Leone Arsenio
Azienda Ospedaliera Universitaria di Parma
PRESIDENTE / PRESIDENT
Andrea Strata
Università di Parma
DIRETToRE RESPoNSABILE / 
DEPUTY EDIToR
Federico Cioni
01-Board.indd   193 29/09/16   11:36
Index
Volume 18 / n. 3 September 2016
 Reviews
195 Komeela Cannoosamy, Rajesh Jeewon
 A critical assessment of nutrition labelling and determinants of its use  
 and understanding
205 Alida Abruzzo, Giuseppe Damiano, Roberta Altomare, Vincenzo Davide Palumbo,  
 Giovanni Tomasello, Salvatore Buscemi, Giulia Lo Monte, Carolina Maione,  
 Giuseppe Buscemi, Attilio Ignazio Lo Monte
 The influence of some dietary components on intestinal microbiota
 Original articles
213 Luisella Vigna, A Cossovich, C Barberi, D Sommaruga, L Neri, D Conti, F De Simone,  
 GM Agnelli, L Riboldi
 Weight loss and body composition change among workers undergoing a meal  
 replacement dietary program: feasibility and efficacy
222 Hülya Yardimci, Gülperi Hakli, Funda Pınar Çakiroğlu, Ayşe Özfer Özçelik
 The correlation between body conception and actual body mass index among  
 adolescents: some variables and their role
231 Elham Fazeli, Mahin Tafazoli, Mohsen Nematy, Narjes Bahri
 The relationship between the dietary protein intake and functional ovarian cysts
236 Seyed Mohammad Hosein Mousavi Jazayeri, Alireza Ostadrahimi, Abdolrasoul Safaiyan, 
 Shahryar Hashemzadeh, Firouz Salehpour
 Effects of four different enteral feeding methods on tumor Necrosis Factor-α 
 (TNF-α) and high sensitive C-Reactive Protein (hs-CRP) in critically Ill Patients: 
 double blinded, randomized controlled trial
242 Ala Ali Qatatsheh, Ibrahim R. Dabbour, Abdallah S. Al-rethaia, Murad A. Al-Holy, 
 Sharaf S. Omar
 Iron status in healthy subjects living in Jordan
249 Sarah Al Nasir, Zubaida Abdel Nabi Bakeet, Nawal Al Badar, Shaista Arzoo
 Study on etiology of iron deficiency anemia and effect of iron supplementation in 
 women of childbearing age
258 Duangkamon Ngarmpattarangkoon, Bunchoo Pongtanakul, Pithi Chanvorachote, 
 Kulwara Meksawan
 Effect of vitamin E supplementation on oxidative stress in  
 non-transfusion-dependent thalassemia
266 Greta Kresic, Mihela Dujmović, Nikolina Mrduljas
 Inadequate water intake of breastfeeding women
276 Mario Migaldi, Giulio Rossi, Alessandro Sgambato, Alberto Farinetti, Anna Vittoria Mattioli
 Histological and immunohistochemical analysis of meat-based food preparations
283 Mario Orlandi, Maria Claudia Curadi, Lucia Monti, Tiziana Maria Piera Cattaneo
 Sialylated oligosaccharides in mare and ass milk: preliminary results
288 Khalid M Elhindi, Nasser A. Al-Suhaibani, Ahmed F. Sharaf El-Din, Sobhy M Yakout, 
 Salem M. Al-Amri
 Effect of foliar-applied iron and zinc on growth rate and essential oil in sweet basil 
 (Ocimum basilicum L.) under saline conditions
299 Saeed Samarghandian, Mohsen Azimi-Nezhad, Abasalt Borji, 
 Tahereh Farkhondeh
 Crocus sativus L. (saffron) extract reduces the extent of oxidative stress and 
 proinflammatory state in aged rat kidney
Mattioli 1885 
srl - Strada di Lodesana 649/sx
Loc. Vaio - 43036 Fidenza (Parma)
tel 0524/530383
fax 0524/82537
www.mattioli1885.com
Direzione Generale
Direttore Generale
Paolo Cioni
Vice Presidente e Direttore Scientifico
Federico Cioni
Direzione Editoriale
Editing Manager
Anna Scotti
Editing
Valeria Ceci
Foreign Rights
Nausicaa Cerioli
Marketing e Pubblicità
Direttore Commerciale
Marco Spina
Responsabile Area ECM
Simone Agnello
Project Manager
Natalie Cerioli
Massimo Radaelli
Responsabile Distribuzione
Massimiliano Franzoni
PRogRESS IN NuTRITIoN
Registrazione Tribunale di Parma 
N. 4 del 21/1/1999
Spedizione in abbonamento postale
Abbonamento annuale euro 57
I dati sono stati trattati elettronicamente e 
utilizzati dall’editore Mattioli 1885 spa per 
la spedizione della presente pubblicazione e 
di altro materiale medico scientifico. Ai sen-
si dell’Art. 13 L. 675/96 è possibile in qual-
siasi momento e gratuitamente consultare, 
modificare e cancellare i dati o semplice-
mente opporsi all’utilizzo scrivendo a: Mat-
tioli 1885 srl - Casa Editrice, Strada della 
Lodesana 249/sx, Loc. Vaio, 43036 Fidenza 
(PR) o a direct@mattioli1885.com
Progress in Nutrition is indexed by: Scien-
ce Citation Index Expanded (SciSearch®); 
Journal Citation Reports/Science Edition; 
Excerpta Medica/Embase, ISI Web of 
Science; Scopus
Impact Factor (released in June 2016): 0.312
02-indice.indd   194 29/09/16   11:36
The influence of some dietary components on intestinal 
microbiota
Alida Abruzzo1, Giuseppe Damiano2, Roberta Altomare3, Vincenzo Davide Palumbo6, 
Giovanni Tomasello5,6, Salvatore Buscemi1, Giulia Lo Monte4, Carolina Maione2, Giuseppe 
Buscemi2,3, Attilio Ignazio Lo Monte2,3
1PhD Course in Surgical Biotechnology and Regenerative Medicine, University of Palermo, Italy; 2University Hospital 
“P.Giaccone”, Palermo, Italy - E-mail: attilioignazio.lomonte@unipa.it; 3Department of Surgical, Oncological and Stomatological 
Disciplines, University of Palermo, School of Medicine, Palermo, Italy; 4School of Biotechnology, University of Palermo, Italy
5Department of Experimental Biomedicine and Clinical Neuroscience, Section of Human Anatomy, (BIONEC), University of 
Palermo, Italy; 6Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
Summary. The gut microbiota is the set of symbiotic microorganisms that resides in our intestine. The interac-
tion between the gut microbiota and the mucosal immune system can be altered as a result of shifts in the com-
position or metabolic activity of the intestinal microflora. Recent studies establish that diet is one of the main 
involved factors in determining the microbial composition of the gut suggesting its role as external factor able to 
promote the onset of specific diseases by disrupting the immune homeostasis. Starting from the evidence that 
the 57% of the gut microbiota’s entire variation are due to dietary alterations this review aims at providing an 
overview of the positive impact of some dietary components on gut microbiota composition.
Key words: dysbiosis, gut microbiota, diet, inflammatory bowel disease, IBD
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Introduction
The human gut microbiota is a densely popu-
lated bacterial community with approximately about 
100 trillions of bacteria and more than 500 different 
species in the colon that can reach a concentration 
or density of 9x1013 units (1). It is a good example of 
mutualistic relationship since the mammalian hosts 
provide a uniquely suited environment in return for 
physiological benefits provided to them by their gut 
microbiota (2). Examples of the latter include the fer-
mentation of indigestible carbohydrates to produce 
short chain fatty acids (SCFA) that are utilized by the 
host, the biotransformation of conjugated bile acids, 
the synthesis of certain vitamins, the degradation of 
dietary oxalates, the hydrolysis of urea by urease activ-
ity, the participation in host nitrogen balance, and the 
modulation of the mucosal immune system. Mainly, 
the microbiota exerts physiological functions that in-
clude the growth inhibition of pathogenic bacteria, the 
absorption of nutrients and minerals, the regulation of 
the intestinal immune system and the signals of gut 
cell renewal, the synthesis of vitamins and amino acids, 
and the degradation of protein compounds (3). The di-
etary components are the energy sources that support 
the microbial community of the large intestine. The 
anaerobic metabolism by the microbial community in 
the colon produces SCFA, CO2, H2 and CH4 (4). SC-
FAs, in particular, play a direct role in the maintenance 
of intestinal health and in the onset of disease. They 
originate from the bacterial fermentation of polysac-
charides, oligosaccharides, and glycoprotein precursors 
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and are produced in different amounts in the different 
tracts of the intestine. SCFAs influence the gut envi-
ronment and the host as regulators of gene expression 
and cell differentiation and anti-inflammatory agents 
(5,6). They are also fundamental for mucous mem-
brane growth control and regulate the proliferation of 
colonic epithelial cells. The butyrate, in particular, en-
hances the growth of a specific group of bacteria such 
as Lactobacilli and Bifidobacteria, which play a very im-
portant role in the physiology of colonocytes (7).
In this review we introduce the preliminary find-
ings reported in literature in order to maintain an 
healthy resident gut microbiota. Prior to this, however, 
a brief description of the microbiota and its alteration 
is given.
Dysbiosis 
The term “dysbiosis” was originally coined by 
Metchnikoff to describe altered pathogenic bacteria 
in the gut (8). This condition leads to qualitative and 
quantitative changes in the intestinal flora, its meta-
bolic activity and its local distribution (9). The dys-
biosis hypothesis states that the modern diet and life-
style, as well as the use of antibiotics, have led to the 
disruption of the normal intestinal microflora. These 
factors result in alterations in bacterial metabolism, as 
well as the overgrowth of potentially pathogenic mi-
croorganisms. It is believed the growth of these bacte-
ria in the intestines results in the release of potentially 
toxic products that play a role in many disease con-
ditions(8), including irritable bowel syndrome (IBS)
(10) and inflammatory bowel disease (IBD)(11,12) as 
well as more systemic conditions such as rheumatoid 
arthritis (13,14). Different studies have shown, in par-
ticular, reduced diversity of the gut microbiota in IBD 
patients (15-18). The most consistent observations of 
altered composition of the gut microbiota are a reduc-
tion in Firmicutes and an increase in Proteobacteria 
(15,16,19,20). 
The reduced diversity of the gut microbiota ob-
served is largely due to a decline in the diversity of 
Firmicutes. Among Firmicutes, has been reported a 
decrease in the Clostridium leptum groups, especially 
Faecalibacterium prausnitzii (16,21,22).
Methods
This review aims to provide an up-to-date over-
view of the influence of some dietary components on 
intestinal microbiota composition.
Literature search
Relevant articles were identified through two 
different search methods: (1) a PubMed search to 
identify related papers and books, using the following 
keywords: gut microbiota, dysbiosis, diet, cereal, cof-
fee, pomegranates, wine, resveratrol, inulin, broccoli, 
banana, chocolate, inflammatory bowel disease; (2) a 
check of the reference lists of original studies or re-
views for additional publications.
Study selection
The title and abstract of each study identified in 
the search was screened to determine the study’s eligi-
bility for full review. The full-text report was retrieved 
if the study investigated or potentially investigated the 
effects of some dietary components on gut microbiota. 
Only human studies published in English were in-
cluded.
Foods that can modulate the intestinal microbiota 
exerting positive effects on health
Some preliminary studies suggest that dysbiosis 
is caused by genetic and environmental factors, rather 
than being a consequence of inflammation.
Zhang et al.(23) reported that dietary alterations 
are responsible for 57% of the gut microbiota’s entire 
variation, whereas genetic background explains only 
12%. Moreover, changes in dietary factors cause both 
quantitative and qualitative shifts in the supply of sub-
strates available to the intestinal microbiota (24). On 
the basis of these observations, it becomes clear that 
dietary factors can lead to the prevention of dysbiosis 
that seems to be the prelude to the onset of several 
diseases such as inflammatory bowel diseases. Keys’ 
studies (25) have showed the nutritional value of the 
Mediterranean Diet that thanks to the high supply of 
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fibres and antioxidants favours the prevalence of sac-
charolytic bacterial species responsible of the short-
chain fatty acids production, while Western Diet 
promotes the shift towards a proteolytic profile which 
leads to dysbiosis (26). Although each adult’s gut 
shows a unique microbiome community with a stable 
structure (core), diet can modulate resident and trav-
eler microbes altering the balance towards a potentially 
healthier microflora (27). Emerging evidences have al-
ready showed that a very low-carbohydrate, high-fat 
(LC) diet compared with a high-carbohydrate, high-
fibre, low-fat (HC) diet leads to reductions in fecal 
output, concentrations of butyrate and total SCFA and 
counts of bifidobacteria (28). 
Furthermore, long-term intake of fiber can reduce 
the risk of developing Crohn’s disease (29). This could 
be explained considering that fibers derived from fruits 
are soluble and so inhibit the translocation of E. Coli 
across Peyer’s patches maintaining the intestinal bar-
rier function. Some fruits are able to activate also the 
aryl hydrocarbon receptor that can mediate protection 
against environmental antigens activating dioxin- or 
xenobiotic –response element sequences. 
Several non-digestible carbohydrates, such as glu-
cans, galactans, arabinoxylans (AX), resistant starch 
(dextrin), can be fermented by the gut microbiota lead-
ing to a switch of microflora’s composition (30,31). Sig-
nificant studies demonstrate that AX added to a high-
fat diet led to an increase in bifidobacteria, particularly 
Bifidobacterium animalis subsp. lactis. AX also restored 
the cecal content of Gram- negative Bacteroides-Pre-
votella spp. and Gram-positive Roseburia spp. bacterial 
populations to control levels, which were decreased fol-
lowing a high-fat diet. Moreover, many human stud-
ies demonstrated that fructose oligosaccharides have a 
bifidogenic effect on human colonic endogenous flora 
(32-34). Additional data showed that inulin-type fruc-
tans have the same effect on humans (35-36). By means 
of these, the growth of bifidobacteria, was measured in 
the stool of human volunteers fed varying amounts of 
prebiotics. Stool slurries were incubated with a specific 
prebiotic and changes in bifidobacteria were quantitat-
ed, the results were mixed and a dose-response curve 
could not be obtained (37). The bifidogenic effect could 
be explained by the fact that prebiotics are preferential 
substrates for bifidobacteria and interact with other bac-
teria causing environmental changes, such as changes in 
luminal pH and other factors. 
Starting from these assumptions, we report a ta-
ble (Table 1) indicating some foods and beverages with 
potentially positive impact on individual’s health.
Chicory, artichokes, Jerusalem artichokes, garlic, onion, as-
paragus
In vivo human studies have confirmed both the 
fermentability and the bifidogenic effect of chicory 
fructooligosaccharides. It was detected not only a sig-
nificant increase in the bifidobacteria population but 
also a profound modification of the composition of the 
fecal flora (31). 
In a double-blind, randomized, placebo-con-
trolled, parallel-group study with forty-five volunteers 
was showed that Jerusalem artichoke inulin or chicory 
inulin can increase the number of bifidobacteria and re-
duce bacteroides/prevotella (38).
Daily consumption of a very-long-chain inu-
lin extracted from globe artichoke confirmed a pro-
nounced prebiotic effect on the human faecal micro-
biota composition (39).
A significative study based on in vitro batch fer-
mentation system with human fecal microbiota evalu-
ate the prebiotic activity of inulin. It was evidenced 
that Fermentation of inulin resulted in a significantly 
greater ratio of Lactobacillus or Bifidobacteria to En-
terobacteria strains (40).
On the basis of these preliminary evidences all the 
foods with high oligofructose and inulin contents such 
as Jerusalem artichokes, garlic, onion and asparagus 
may help to maintain an healthy intestinal microenvi-
ronment thanks to their prebiotic activity. 
Pomegranates and wine
It has been postulated that some phenolic com-
pounds can readily contribute to modulation of the gut 
bacteria (41-43) since they are poorly absorbed in the 
upper part of the gut and can reach the colon to be fer-
mented by bacteria. For example, polyphenols present 
in pomegranates (ellagitannins and anthocyanins) have 
important antioxidant and anti-inflammatory bioactivi-
ties (44). One study demonstrated that exposure of gut 
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Food / Beverage
Whole grains (eg. barley, 
rice, wheat)
Broccoli, savoy cabbage, 
Brussels sprouts
Coffee
Pomegranates, wine
Chicory, artichokes, Je-
rusalem artichokes, gar-
lic, onion, asparagus
Banana
Chocolate,
wild berries, strawber-
ries, 
Effective components
Insoluble fibers
Glucosinolates
Melanoidins
Phenolics
Inulin
Fructooligosaccharides 
Polyphenolics
Effect
Feed the intestinal mi-
crobial population con-
tributing to its equilib-
rium
Feed the intestinal mi-
crobial population
Feed the intestinal mi-
crobial population
Modulate the intestinal 
microbiota population
Can feed selectively 
some good bacteria (e.g. 
Bifidobacteria, Lactoba-
cilli)
Modulate the intestinal 
microbiota population
Can feed selectively 
some good bacteria (e.g. 
Bifidobacteria, Lactoba-
cilli)
Mechanism of Action
Increase populations of 
bifidobacteria and lacto-
bacilli,
Increase of ferulic acid 
concentrations in blood
Changes in bacterial 
metabolic activity
Increase the population of 
Bifidobacterium spp. and 
in some cases increase the 
metabolic activity of Bifi-
dobacterium spp. 
Exposure of by-product 
with faecal bacteria en-
hanced the growth of 
Bifidobacterium spp. 
and Lactobacillus spp. 
and in addition in-
creased concentrations 
of short chain fatty acids 
Wine phenolics inhibit 
detrimental bacteria 
and stimulate beneficial 
bacteria, in particular 
Lactobacteria and Bifi-
dobacteria
Induce an increase in the 
number of bifidobacteria 
in human faecal flora
Transgalactosylated di-
saccharide increased the 
number of bifidobacteria 
and lactobacilli
Increase in Bifidobacte-
rial levels
Increase in the number 
of Bifidobacteria and 
Lactobacilli 
Ref.
Costabile et al.,2008 
Christensen et al,2013
Connolly et al,2010
Li et al. 2009
Jaquet et al.,2009
Nakayama et al,2013
Basu & Penugonda,2009
Bialonska et al.,2010
Biasi et al.,2014
Queipo-Ortuno et al. 
2012
Kleessen et al,2007
Costabile et al,2010
Jung et al,2015
Mitsou et al,2011
Tuohy et al,2012
Tzounis et al,2011
Etxeberria et al,2013
Table 1. Foods and beverage that may have a positive impact on individual’s health.
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bacteria to pomegranate by-products enhanced the  to-
tal growth of Bifidobacterium spp. and Lactobacillus spp. 
without influencing the C. coccoides - E. rectale and the 
Clostridium histolyticum groups (45). Some researchers 
suggest that pomegranate oligomers composed of gal-
lic acid, ellagic acid and glucose units may account for 
the enhanced growth of specific bacteria associated with 
benefic effects.
It has been hypothesized that wine phenolics may 
act as prebiotics and that their activity may derive from 
their ability to interact with microbes’ growth, both by 
inhibiting detrimental bacteria and by stimulating ben-
eficial bacteria in the gut, in particular Lactobacteria and 
Bifidobacteria (46,47).
A group of research investigated also the effect of 
polyphenols derived from fruits and showed that they 
are able to inhibit the growth and adhesion of patho-
gens (S. typhimurium) to a human gut cell line and to 
enhance the proliferation and adhesion of a probiotic, 
L. rhamnosus (29). 
Broccoli, Brussels sprouts
In a randomized, crossover, controlled feeding study 
fecal samples were collected from 17 participants at the 
end of 2 14-d intake periods: a low-phytochemical, low-
fiber basal diet and a high cruciferous vegetable diet. It 
was evidenced that cruciferous vegetable consumption 
can alter human gut bacterial community (48).
Coffee
Jaquet and co-workers (49) illustrate a means of 
modulating the human microbiota through coffee con-
sumption. Sixteen healthy adult volunteers consumed a 
daily dose of three cups of coffee during 3 weeks. Fecal 
samples were collected before and after the consump-
tion of coffee, and the impact of the ingestion of the 
product on the intestinal bacteria as well as the quan-
tification of specific bacterial groups was assessed using 
nucleic acid-based methods. Data obtained showed that 
the population of Bifidobacterium spp., a bacterial group 
of reputed beneficial effects, increased after the 3-week 
test period. The same results were obtained by a Japa-
nese study in 2013 (50).
Whole grain wheat
The efficacy of whole-grain (WG) wheat com-
pared with wheat bran (WB) alone was evaluated in a 
double-blind, placebo-controlled crossover study (51). 
Thirty-one healthy subjects were randomized in two 
groups and were fed either WG wheat breakfast cereal 
(48 g/d), or WB breakfast cereal (48 g/d) as placebo for 
3 weeks. After a 2-weeks washout phase volunteers were 
then crossed over to the other breakfast cereal treatment 
for another 3 weeks. Fasting blood, 24h urine and single 
stool samples were collected before and after treatment 
with the cereals, and changes within the gut microbiota 
and its metabolic output in terms of SCFA profiles and 
plasma. It was demonstrated that is possible to benefi-
cially modulate the gastrointestinal microbiota and their 
activities. WG and WB have a differential impact on 
the microbial ecology of the human gut. Moreover, WG 
breakfast cereal reveal a prebiotic mode of activity since 
they have been associated with increased populations 
of bifidobacteria and lactobacilli compared to WB. These 
results suggest that it would be possible to plan dietary 
interventions able to ensure the maintenance of a bal-
anced microflora.
In postmenopausal women following a 12-week 
energy-restricted dietary intervention with whole-grain 
or refined wheat was evidenced a prebiotic effect in the 
first group (52). In particular, for the first time the im-
pact of oat grain on the microbial ecology of the human 
gut was reported and was highlighted its ability of in-
creasing Bifidobacterium population (53).
Banana
Thirty-four healthy women having Body Mass 
Index (BMI) 24-30 kg/m, age 19-45 years, no his-
tory of gastrointestinal disease and no antibiotic and 
other medication participated in a controlled trial (54). 
All women were asked to maintain their usual dietary 
habits for 60 days and they were randomly assigned to 
consume twice a day a pre-meal snack, either one me-
dium banana, or one cup of banana-flavoured drink or 
one cup of water (control group). Stool samples were 
collected at baseline, on days 30 and 60 of interven-
tion for enumeration of total anaerobes, bifidobacteria 
and lactobacilli by plate count techniques, as well as 
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for pH and short chain fatty acids (SCFAs) measure-
ment. Gastrointestinal symptoms were also recorded. 
Mean bifidobacterial levels were increased only in the 
banana group both at 30 and 60 days of intervention. 
Daily consumption of bananas representing therefore 
an healthy eating behaviour, which may induce bifido-
genesis in women experiencing body weight problems.
Chocolate, wild berries, strawberries
In a controlled, double-blind, randomized clinical 
trial, researchers compared the outcomes of consum-
ing a high-cocoa vs. a low-cocoa flavanol drinks (55). 
Their results show a significant increase in certain gut 
microbes such as Bifidobacteria and Lactobacilli. On the 
other hand, a significant decrease in Clostridia, which 
are a class of the Firmicutes, was noted. According to 
the same study, these changes in bacterial population 
was accompanied by changes in other biological mark-
ers such as triglyceride and C-reactive protein concen-
tration.
Additional studies have showed that polyphenol-
rich chocolate and certain fruits induced an increase in 
fecal bifidobacteria (56,57).
Discussion
Some foods may contribute to the development 
of exacerbations in several diseases (i.e. inflammatory 
bowel diseases) via modulation of the immune system 
and the intestinal microbiota. In particular, the intesti-
nal microbiota has a key role in this phase as reported 
by recent findings, showing that diversion of the fecal 
stream and treatment with antibiotics can improve the 
disease activity. Different studies evidenced a different 
composition and a less bacterial diversity in inflamed 
vs. non-inflamed mucosal samples of patients with 
active and inactive IBD (37). Even though, causative 
bacterial species are still unknown. Recent work has 
suggested that individuals can be classified into ‘en-
terotypes’ based on the abundance of key bacterial taxa 
in gut microbial communities. However, the general-
ity of enterotypes across populations, and the existence 
of similar cluster types for other body sites, remains 
to be evaluated (38). This emerging evidence will lead 
to clarify if individuals with a Bacteroides-predominant 
gut microbiota may have a higher incidence of diseases 
due to the Western diet. Once the possible increased 
risk has been ascertained, it would be reasoneable to 
direct towards long-term dietary interventions able to 
induce a switch towards a Prevotella-predominant mi-
crobiota. It should be taken into account the hypothesis 
that the mechanism of action of dietary factors do not 
involve only a change in the microbiota composition 
but rather influence its metabolism leading to the pro-
duction of metabolites such as the gas trimethylamine 
that may cause the development of disease. In our 
work we suggest some dietary components that may 
be able to maintain a well being state preventing the 
perturbation of microbiota homeostasis. A balanced 
diet characterized by a high consumption of specific 
type of vegetables and fruits along with a moderate in-
take of meat may have beneficial effects on individual’s 
long-term health. Anyhow further studies are needed 
to better understand the interaction between diet and 
intestinal microbiota in the hope of finding new thera-
peutic or preventive strategies.
Conclusions
On the basis of a bacterial mediated immune 
regulation it become reasonable trying to maintain a 
healthy environment in the gut. These evidences has 
raised the possibility that some form of modulation 
of the intestinal microbiota may constitute a potential 
therapeutic basis for the disease. Given the plasticity of 
microbiota, it is presumable that dietary interventions 
could positively affect health status, either by keep-
ing a physiological gut flora or by helping to reverse a 
dysbiosis condition. Some preliminary findings indi-
cate that foods such as pomegranates, chicory, whole 
grains, chocolate can be able to modulate the com-
position and metabolic activity of intestinal microbial 
population. Further studies are required to confirm the 
mechanisms of action of these foods on microbiota 
and to better understand the pathways by which food 
interacts with microbiome in order to design highly 
personalised nutritional strategies.
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